Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Guidant to Use LifeShirt to Develop Heart Failure Devices

By HospiMedica staff writers
Posted on 16 Dec 2002
To aid its development of new diagnostic and therapeutic features for future heart failure devices, Guidant Corp. More...
(Indianapolis, IN, USA) has signed a contract with VivoMetrics (Ventura, CA, USA) that will permit Guidant to use the LifeShirt monitoring system of VivoMetrics over the next four years for research purposes. Guidant has also licensed the company's VivoLogic software for processing and analyzing the collected data.

The LifeShirt system is a noninvasive, continuous ambulatory monitoring system that collects data on cardiac and respiratory function and other physiologic parameters and correlates them over time. The sensors monitor heart function, posture, and physical activity. A diary captures subjective patient experiences. Guidant plans to use the system to monitor changes in physiologic signals associated with congestive heart failure (CHF).

"The LifeShirt system will allow us, for the first time, to obtain data gathered simultaneously from a suite of physiologic sensors on a long-term, ambulatory basis. Prior to this, it has not been practical to gather data with high fidelity continuously, day after day, as the patients go about their normal daily activities,” said John Hatlestad, managing scientist at Guidant for the project.




Related Links:
Guidant
VivoMetrics

Gold Member
Handheld Blood Glucose Analyzer
STAT-Site
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Immobilization System
Cranial 4Pi Immobilization
Tourniquet System
heidi– mein Tourniquet
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Artificial intelligence (AI) standalone performance and reader performance with versus without AI assistance. (A) Receiver operating characteristics (ROC) curve for AI standalone performance in the US dataset (AUC 0.899, 95% CI 0.858 to 0.939). (B) ROC curve for AI standalone performance in the Korean dataset (AUC 0.963, 95% CI 0.946 to 0.975). (C) Pooled reader ROC without (AUC 0.718) versus with (AUC 0.852) AI assistance in the Korean dataset; P<0.001. AUC, area under the receiver operating characteristics curve. (Leonard Sunwoo et al., Journal of NeuroInterventional Surgery (2026). DOI: 10.1136/jnis-2026-025339)

AI Improves Non-Contrast CT Interpretation for Time-Sensitive Stroke Assessment

Acute ischemic stroke occurs when a blood vessel in the brain becomes blocked, requiring rapid diagnosis to enable timely reperfusion therapy. Emergency departments often use computed tomography angiography... Read more

Surgical Techniques

view channel
Image: Researchers developed a handheld photothermal mid-infrared spectroscopic imaging (MIRSI) system that measures just 8 square inches. Probe light from a visible (red) diode laser and pump light from a modulated quantum cascade laser (QCL) are coupled into optical fibers and delivered to a flexible, handheld imager (blue dashed box). The beams are combined at a short-pass dichroic mirror and focused onto the sample using an off-axis parabolic mirror (OAP). (Image Credit:Rohith Reddy, University of Houston)

Handheld Infrared Imaging Device Supports Tumor Margin Assessment During Surgery

Accurately determining tumor margins during surgery remains challenging. Frozen-section pathology takes time and can miss residual disease, potentially leading to repeat surgery and delayed therapy.... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.